Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Cash Flow Reinvestment Rate
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥9.15 Million (capex CN¥9.15 Million ) from operating cash flow of CN¥44.34 Million. Explore 605199 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hainan Huluwa Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Hainan Huluwa Pharmaceutical Group Co Ltd across 9 annual periods. Also explore Hainan Huluwa Pharmaceutical Group Co Lt assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Hainan Huluwa Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Hainan Huluwa Pharmaceutical Group Co Lt (605199) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥83.67 Million | CN¥136.85 Million | CN¥83.67 Million | ▼ -98.3% |
| 2023 | 35.87x | CN¥1.01 Billion | CN¥28.25 Million | CN¥489.20 Million | ▲ +1979.0% |
| 2022 | 1.73x | CN¥411.86 Million | CN¥238.71 Million | CN¥392.32 Million | ▲ +28.4% |
| 2021 | 1.34x | CN¥137.74 Million | CN¥102.48 Million | CN¥137.62 Million | ▼ -92.7% |
| 2020 | 18.53x | CN¥61.14 Million | CN¥3.30 Million | CN¥59.42 Million | ▲ +4256.9% |
| 2019 | 0.43x | CN¥61.45 Million | CN¥144.51 Million | CN¥58.40 Million | ▼ -82.1% |
| 2018 | 2.37x | CN¥75.34 Million | CN¥31.80 Million | CN¥72.82 Million | ▲ +34.7% |
| 2017 | 1.76x | CN¥158.23 Million | CN¥89.96 Million | CN¥157.58 Million | ▲ +9.5% |
| 2016 | 1.61x | CN¥104.40 Million | CN¥64.96 Million | CN¥40.99 Million | — |